News & Reports 2017-04-05T16:38:50+00:00

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Portland biotech community finally gets its wish: a new lab-office project

Elizabeth Hayes, Portland Business Journal

Summit Development Group to invest $12M in Central Eastside lab-office development

One of the biggest obstacles for biotech companies looking to expand in Portland is the city’s lack of suitable lab space.

That situation is about to change. A new 40,000-square-foot lab-office development, scheduled to get underway in April, is slated to open in the fall in Portland’s Central Eastside.

Summit Development Group bought a 100-year-old, three-story warehouse building on the corner of Southeast […]

March 1st, 2018|

Legacy Health Foundation collects its largest grant for cancer research

Elizabeth Hayes, Portland Business Journal

The Wayne D. Kuni & Joan E. Kuni Foundation has awarded $5 million to Legacy Health Foundation to found a cancer research project.

The grant, the largest the Foundation has collected, will fund research into how cancer can be targeted by manipulating adenosine kinase, an enzyme that controls cell growth.

The research is led by Detlev Boison, Dow Chair of Neurology and director of neurobiology research and basic and translational research at Legacy […]

February 22nd, 2018|

Legislature 2018: Nosse’s new drug pricing bill is slimmed down but still controversial

By Elizabeth Hayes, Staff Reporter
Portland Business Journal

Rep. Rob Nosse, undeterred by the failure of his comprehensive prescription drug pricing bill last year, returned the House Health Care Committee on Monday to sell a new, slimmed down version.

House Bill 4005 would force more transparency on drug manufacturers, but it doesn’t specifically impose price controls. Nosse hopes that will make it an easier sell. The Portland Democrat has bipartisan support this time around.

“House Bill […]

February 8th, 2018|

‘Lifting all boats’: Kate Brown focuses on 2019 education plan in state of the state speech

SALEM — Gov. Kate Brown opened the 35-day legislative session Monday with a speech laying out her plan to improve technical education and training programs so more Oregonians can land jobs in growth industries such as bioscience and health care.

Much of the plan centers on a $300 million proposal she said she will bring to the […]

February 6th, 2018|

Two words helped fight his cancer: ‘Sequence me’

“I didn’t like that,” said Bryce said about learning he had 21 months to live. “That was a pretty stinky prognosis.”

By Tracy Barry, KGW8 News (Original Article)
Watch the video

Bryce Olson is a runner. He hadn’t been to a doctor in five years, because […]

January 24th, 2018|


House leaves out ObamaCare fix from must-pass funding billObamaCare payments aimed at lowering premiums will not be included in the House's government funding bill, in a significant defeat for ba [...]

Medicxi has created an "ideas factory" to boost its capacity to turn early-stage science into pipelines of drug candidates and startups to develop them. The VC fund is setting up the venture [...]

Kerrisdale Capital has fixed on cystic fibrosis biotech Proteostasis Therapeutics in its latest attack. The short seller launched the assault after seeing shares in Proteostasis rise 200% in three mon [...]

Trump unveils opioid planPresident Trump vowed on Monday to toughen the country's borders as a way to fight the opioid crisis that's killing more Americans per year than traffic accidents.Tr [...]

Immuno-oncology biotech Five Prime has outlicensed a medication from its protein discovery platform exclusively to Belgium biopharma UCB. [...]

Affimed has named Leila Alland, M.D., as its CMO. Alland landed the role on the strength of a CV that features stints spent advancing clinical oncology programs at AstraZeneca, Bristol-Myers Squibb an [...]

Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast as it looks to help early-stage biomedical work get off the ground with more lab space. [...]

Four former heads of the Food and Drug Administration (FDA) are urging Congress to abandon bills that would allow terminally ill patients access to experimental drugs not yet approved by the agency. T [...]